Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

Kilickap, S.Ozturk, A.Karadurmus, N.Korkmaz, T.Yumuk, P.Cicin, I.Paydas, S.2024-02-232024-02-2320181556-08641556-1380https://hdl.handle.net/20.500.12452/18035[Abstract Not Availabe]eninfo:eu-repo/semantics/closedAccessNsclcAlk InhibitorCrizotinibCrizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from TurkeyConference Object1310S477S478Q1WOS:000454014501235Q1